Maged Shenouda, CFO at Relmada Therapeutics, holds 34.90K shares in Relmada Therapeutics (Ticker: RLMD), holds 62.50K shares in First Wave Bio (Ticker: FWBI). Most recently, Maged Shenouda Bought ― shares of Relmada Therapeutics on Jan 31, 2024 for an estimated value of 125.53K.